These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8837713)

  • 61. Dopamine D3 receptor gene Ser9Gly variant and schizophrenia: association study and meta-analysis.
    Jönsson EG; Flyckt L; Burgert E; Crocq MA; Forslund K; Mattila-Evenden M; Rylander G; Asberg M; Nimgaonkar VL; Edman G; Bjerkenstedt L; Wiesel FA; Sedvall GC
    Psychiatr Genet; 2003 Mar; 13(1):1-12. PubMed ID: 12605094
    [TBL] [Abstract][Full Text] [Related]  

  • 62. DRD4 exon 3 variants are not associated with symptomatology of major psychoses in a German population.
    Serretti A; Lorenzi C; Mandelli L; Cichon S; Schumacher J; Nöthen MM; Rietschel M; Tullius M; Ohlraun S
    Neurosci Lett; 2004 Sep; 368(3):269-73. PubMed ID: 15364409
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Variability of 5-HT2C receptor cys23ser polymorphism among European populations and vulnerability to affective disorder.
    Lerer B; Macciardi F; Segman RH; Adolfsson R; Blackwood D; Blairy S; Del Favero J; Dikeos DG; Kaneva R; Lilli R; Massat I; Milanova V; Muir W; Noethen M; Oruc L; Petrova T; Papadimitriou GN; Rietschel M; Serretti A; Souery D; Van Gestel S; Van Broeckhoven C; Mendlewicz J
    Mol Psychiatry; 2001 Sep; 6(5):579-85. PubMed ID: 11526472
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The dopamine D3 receptor gene: no association with bipolar affective disorder.
    Shaikh S; Ball D; Craddock N; Castle D; Hunt N; Mant R; Owen M; Collier D; Gill M
    J Med Genet; 1993 Apr; 30(4):308-9. PubMed ID: 8098068
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Use of polymerase chain reaction nad denaturing gradient gel electrophoresis to identify polymorphisms in three exons of dopamine D2 receptor gene in schizophrenic and delusional patients.
    Catalano M; Nobile M; Novelli E; Smeraldi E
    Neuropsychobiology; 1992; 26(1-2):1-3. PubMed ID: 1475034
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Association of DRD2 gene polymorphisms with mood disorders: a meta-analysis.
    Zou YF; Wang F; Feng XL; Li WF; Tian YH; Tao JH; Pan FM; Huang F
    J Affect Disord; 2012 Feb; 136(3):229-37. PubMed ID: 21130502
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Association study of schizophrenia and the dopamine D3 receptor gene locus in two independent samples.
    Nimgaonkar VL; Sanders AR; Ganguli R; Zhang XR; Brar J; Hogge W; Fann WE; Patel PI; Chakravarti A
    Am J Med Genet; 1996 Nov; 67(6):505-14. PubMed ID: 8950407
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Linkage of mood disorders with D2, D3 and TH genes: a multicenter study.
    Serretti A; Macciardi F; Cusin C; Lattuada E; Souery D; Lipp O; Mahieu B; Van Broeckhoven C; Blackwood D; Muir W; Aschauer HN; Heiden AM; Ackenheil M; Fuchshuber S; Raeymaekers P; Verheyen G; Kaneva R; Jablensky A; Papadimitriou GN; Dikeos DG; Stefanis CN; Smeraldi E; Mendlewicz J
    J Affect Disord; 2000 Apr; 58(1):51-61. PubMed ID: 10760558
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Variation at the DAOA/G30 locus influences susceptibility to major mood episodes but not psychosis in schizophrenia and bipolar disorder.
    Williams NM; Green EK; Macgregor S; Dwyer S; Norton N; Williams H; Raybould R; Grozeva D; Hamshere M; Zammit S; Jones L; Cardno A; Kirov G; Jones I; O'Donovan MC; Owen MJ; Craddock N
    Arch Gen Psychiatry; 2006 Apr; 63(4):366-73. PubMed ID: 16585465
    [TBL] [Abstract][Full Text] [Related]  

  • 70. New dopamine receptor, D2(Longer), with unique TG splice site, in human brain.
    Seeman P; Nam D; Ulpian C; Liu IS; Tallerico T
    Brain Res Mol Brain Res; 2000 Mar; 76(1):132-41. PubMed ID: 10719223
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Quantification of neuroreceptors in the living human brain: IV. Effect of aging and elevations of D2-like receptors in schizophrenia and bipolar illness.
    Wong DF; Pearlson GD; Tune LE; Young LT; Meltzer CC; Dannals RF; Ravert HT; Reith J; Kuhar MJ; Gjedde A
    J Cereb Blood Flow Metab; 1997 Mar; 17(3):331-42. PubMed ID: 9119906
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The influence on the schizophrenic symptoms by the DRD2Ser/Cys311 and -141C Ins/Del polymorphisms.
    Himei A; Koh J; Sakai J; Inada Y; Akabame K; Yoneda H
    Psychiatry Clin Neurosci; 2002 Feb; 56(1):97-102. PubMed ID: 11929577
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mismatch PCR RFLP detection of DRD2 Ser311Cys polymorphism and schizophrenia.
    Hattori M; Nanko S; Dai XY; Fukuda R; Kazamatsuri H
    Biochem Biophys Res Commun; 1994 Jul; 202(2):757-63. PubMed ID: 7914079
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Association study of dopamine receptor genes polymorphism with cognitive functions in bipolar I disorder patients.
    Zhao L; Lin Y; Lao G; Wang Y; Guan L; Wei J; Yang Z; Ni P; Li X; Jiang Z; Li T; Hao X; Lin D; Cao L; Ma X
    J Affect Disord; 2015 Jan; 170():85-90. PubMed ID: 25233244
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Association study of three polymorphisms in the dopamine D2 receptor gene and schizophrenia in the Russian population.
    Monakhov M; Golimbet V; Abramova L; Kaleda V; Karpov V
    Schizophr Res; 2008 Mar; 100(1-3):302-7. PubMed ID: 18255274
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dopamine receptor D2 and D4 genes, GABA(A) alpha-1 subunit genes and response to lithium prophylaxis in mood disorders.
    Serretti A; Lilli R; Lorenzi C; Franchini L; Di Bella D; Catalano M; Smeraldi E
    Psychiatry Res; 1999 Jul; 87(1):7-19. PubMed ID: 10512150
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dopamine D3 receptor variant and tardive dyskinesia.
    Rietschel M; Krauss H; Müller DJ; Schulze TG; Knapp M; Marwinski K; Maroldt AO; Paus S; Grünhage F; Propping P; Maier W; Held T; Nöthen MM
    Eur Arch Psychiatry Clin Neurosci; 2000; 250(1):31-5. PubMed ID: 10738862
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Decreased levels of dopamine D3 receptor mRNA in schizophrenic and bipolar patients.
    Vogel M; Pfeifer S; Schaub RT; Grabe HJ; Barnow S; Freyberger HJ; Cascorbi I
    Neuropsychobiology; 2004; 50(4):305-10. PubMed ID: 15539862
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Dopamine D3 receptor gene not associated with symptomatology of major psychoses.
    Serretti A; Lattuada E; Cusin C; Lilli R; Lorenzi C; Smeraldi E
    Am J Med Genet; 1999 Oct; 88(5):476-80. PubMed ID: 10490702
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Preliminary evidence that negative symptom severity relates to multilocus genetic profile for dopamine signaling capacity and D2 receptor binding in healthy controls and in schizophrenia.
    Eisenstein SA; Bogdan R; Chen L; Moerlein SM; Black KJ; Perlmutter JS; Hershey T; Barch DM
    J Psychiatr Res; 2017 Mar; 86():9-17. PubMed ID: 27886638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.